During the past 3 years, the average EPS without NRIGrowth Rate was 51.30% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 51.80% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 24.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Delivra Health Brands's highest 3-Year average EPS without NRI Growth Rate was 62.20% per year. The lowest was -80.70% per year. And the median was 11.85% per year.
Delivra Health Brands (OTCPK:DHBUF) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Delivra Health Brands EPS (Diluted) Related Terms
Delivra Health Brands EPS (Diluted) Historical Data
* Premium members only.
The historical data trend for Delivra Health Brands's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delivra Health Brands PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's PE Ratio distribution charts can be found below:
* The bar in red indicates where Delivra Health Brands's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Delivra Health Brands's Diluted EPS for the fiscal year that ended in Jun. 2025 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delivra Health Brands (DHBUF) has a EPS (Diluted) of $-0.02 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Delivra Health Brands and its competitors.
Is Delivra Health Brands' EPS (Diluted) too high?
Delivra Health Brands' current EPS (Diluted) is $-0.02. Overall, Delivra Health Brands has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Delivra Health Brands' EPS (Diluted) compare to ZTS and UTHR?
Delivra Health Brands' EPS (Diluted) of $-0.02 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Drug Manufacturers company?
A good EPS (Diluted) depends on the Drug Manufacturers industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Delivra Health Brands and its competitors. Delivra Health Brands's current EPS (Diluted) is $-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Based on GuruFocus' analysis, Delivra Health Brands (DHBUF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.16, compared to a current price of $0.07 — trading 56.2% below its estimated fair value. The current EPS (Diluted) is $-0.02. Delivra Health Brands' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Delivra Health Brands (DHBUF), the current EPS (Diluted) is $-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Delivra Health Brands (DHBUF) Overvalued in 2026?
Based on GuruFocus' analysis, Delivra Health Brands stock appears to be undervalued.
The current stock price of $0.07 is trading 56.2% below its estimated GF Value™ of $0.16.
GuruFocus considers Delivra Health Brands to be Possible Value Trap.
Key valuation signals for DHBUF:
EPS (Diluted): $-0.02
GF Value™: $0.16 vs. price of $0.07 (56.2% below fair value)
No single metric tells the full story. See the DHBUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.
28GF Score
Get the complete analysis for DHBUF
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHBUF has been successfully added to your 
